Serum amyloid A levels in patients with liver diseases

doi:10.3748/wjg.v25.i43.6440

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 43

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7924)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

443

WORD

240

HTML

3878

Figures (1-1)

284

Tables (1-5)

242

Sum=5087

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1010

Download

1827

Sum=2837

Nov 21, 2019 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 21, 2019; 25(43): 6440-6450
Published online Nov 21, 2019. doi: 10.3748/wjg.v25.i43.6440

Table 5 Correlation of serum amyloid A and C-reactive protein levels among patients with various liver diseases

Disease	SAA (mg/L)		CRP (mg/L)		¹Spearman’s rank correlation coeffi-cient	P value
Disease	mean ± SD	Median (minimum-maximum)	mean ± SD	Median (minimum-maximum)	¹Spearman’s rank correlation coeffi-cient	P value
CHB	3.984 ± 4.743	3.250 (0.80-39.90)	4.398 ± 6.522	1.500 (0.30-25.40)	0.620	< 0.001
Autoimmune liver disease	19.73 ± 24.81	13.70 (3.30-108.0)	9.633 ± 5.977	9.100 (1.20-19.60)	0.504	0.020
Pyogenic liver abscess	398.4 ± 246.8	413.5 (62.20-871.0)	138.8 ± 57.46	141.1 (22.90-271.3)	0.508	0.045
Drug-induced liver injury	8.036 ± 1.519	6.800 (3.40-26.20)	6.490 ± 2.616	2.850 (0.30-25.30)	0.219	0.544

¹The Spearman’s rank correlation test was used to determine correlation between groups. SAA: Serum amyloid A; CRP: C-reactive protein.

Citation: Yuan ZY, Zhang XX, Wu YJ, Zeng ZP, She WM, Chen SY, Zhang YQ, Guo JS. Serum amyloid A levels in patients with liver diseases. World J Gastroenterol 2019; 25(43): 6440-6450
URL: https://www.wjgnet.com/1007-9327/full/v25/i43/6440.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i43.6440